What Doctors Don't Tell YouCOX-2 AGAIN: Sorry, we haven’t finished with you yet
This is a special alert for anyone taking drugs for their arthritis, and especially if you are taking a COX-2 inhibitor, supposedly a safer option than the older NSAID painkillers, or a TNF-blocking drug for rheumatoid arthritis.
Vioxx (rofecoxib) is the first of a new kind of analgesic to be licensed in the UK. It employs a pioneering technology called COX-2 (selective cyclo oygenase 2 inhibitors), which is supposed to o ...
Things are seriously unravelling for big pharma at the moment. Within days of Merck withdrawing its painkiller Vioxx, a leading Food and Drug Administration official has warned that five of the world's best-selling drugs may also have an...
The withdrawal of a drug from the market would hardly seem grounds for Christmas cheer, but it may be simply an indication that the winds of change are finally upon us.
It's been discovered that the discredited painkiller Vioxx had been approved for use by children just days before the manufacturer removed it from the market. The drug, one of the new generation of painkillers known as COX-2 inhibitors, almost...
The drugs industry has, for years, enjoyed a protected and privileged position that has allowed it to kill sections of its market with impunity. Sadly, those heady days seem to be coming to an end, at least in the United States.
Hard on the heels of the COX-2 debacle, the US Food and Drug Administration, which somehow seems to have developed a conscience, has recently issued a Public Health Advisory targeting all non-steroidal anti-inflammatory drugs (NSAIDs) as worthy of...
The decision last Friday by the FDA, America's drug regulator, to allow the COX-2 painkiller Vioxx back on the shelves after it had been voluntarily withdrawn by the manufacturer will surprise some. It is even more surprising after hearing the...
Here's an update for readers who read last week's bulletin item about the FDA's unexpected decision to allow the discredited COX-2 drug Vioxx back on the market after the manufacturer had voluntarily withdrawn it.
